OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial.

MLA

Gonzalez, Cristian D., et al. “OnabotulinumtoxinA Improves Oral Aperture in Patients with Scleroderma: A Small Clinical Trial.” Journal of the American Academy of Dermatology, vol. 89, no. 5, Nov. 2023, pp. 952–58. EBSCOhost, https://doi.org/10.1016/j.jaad.2023.04.069.

APA

Gonzalez, C. D., Pamatmat, J. J., Burningham, K. M., Yang, M., & Goff, H. W. (2023). OnabotulinumtoxinA improves oral aperture in patients with scleroderma: A small clinical trial. Journal of the American Academy of Dermatology, 89(5), 952–958. https://doi.org/10.1016/j.jaad.2023.04.069

Chicago

Gonzalez, Cristian D., Jarod John Pamatmat, Kevin M. Burningham, Michelle Yang, and Heather W. Goff. 2023. “OnabotulinumtoxinA Improves Oral Aperture in Patients with Scleroderma: A Small Clinical Trial.” Journal of the American Academy of Dermatology 89 (5): 952–58. doi:10.1016/j.jaad.2023.04.069.